| Similar Articles |
|---|
 |
Bio-IT World
November 2005 |
News Blast Applied Biosystems contributes 400,000 primers... Researchers have discovered the full genetic sequence of many different strains of the flu... Sigma-Aldrich launches Panorama Human Cancer Version 1 Protein Functional Microarray...   |
The Motley Fool
December 31, 2009
Brian Orelli |
Make Money Even When Drugs Fail Biotech growth potential without as much risk can come from innovations that help drugmakers discover new drugs. |
BusinessWeek
February 9, 2004
Catherine Arnst |
What You Need To Know About Avian Flu The current avian flu outbreak in Asia is the fifth since 1997 to infect humans. This has raised a red flag for infectious disease experts, who fear the strain could mutate and spark a devastating flu pandemic. |
Chemistry World
July 2010
Hayley Birch |
Special Report: Health breakthroughs of the decade New discoveries have been made with cancer vaccines, genomics, statin drugs, allosteric modulators, and RNA interference during the last decade. |
The Motley Fool
October 5, 2006
Ralph Casale |
RNAi: Nobel Prize-Winning Biotechnology While drugs based on RNAi knockdown technology may have the potential to become the next big thing in biotechnology, they are still a long way from becoming FDA-approved marketable entities. But it's never too soon to start keeping an eye on the future. Investors, take note. |
Chemistry World
January 22, 2013
Andrew Turley |
Flu vaccine without the eggs approved Flublok from US biotech Protein Sciences has become the first flu vaccine made using an insect virus to win marketing approval in the US. |
BusinessWeek
August 26, 2010
Tom Randall |
Cocktails Are Next For Cancer-Drug Makers Taking a cue from the cocktails of drugs that have made AIDS survivable, drugmakers are pursuing combination therapies against cancer. |
AskMen.com
Jacob Franek |
Avian Influenza 101 Here is everything you need to now about avian influenza so that you can better protect yourself. |
The Motley Fool
March 16, 2006
Rich Duprey |
Avian Flu Ruffling Feathers Roche Pharmaceuticals boosts anti-flu drug production to quiet calls for generics. While the situation bears watching for now, it's not necessarily something for investors to get their feathers ruffled about. |
BusinessWeek
June 16, 2011
Langreth & Cortez |
When Two Cancer Drugs Are Better Than One Drugmakers are collaborating to test combinations of genetically targeted cancer drugs in hopes of boosting survival rates. |
Scientific American
July 2009
Christine Soares |
Could Animal Surveillance Have Seen Swine Flu Coming? The surveillance of animals for new flu viruses has lagged behind preparations for the human pandemics that can be caused by the bugs |
The Motley Fool
June 29, 2010
Brian Orelli |
Redeploying Capital? Investors Hope So. Selling a business unit won't help Abbott Labs diversify. |
The Motley Fool
February 4, 2010
Brian Orelli |
Glaxo Brings Home the Bacon Swine flu gives GlaxoSmithKline the boost, but how long will it last? |
The Motley Fool
November 30, 2006
Brian Lawler |
Happy (Sniffle) Holidays (Cough) It's flu season again, and the market for influenza vaccines is hot. Pharma investors, take note. |
The Motley Fool
May 31, 2011
Brian Orelli |
Profit From This Growing Drug Trend Cancer drugs press on. |
The Motley Fool
April 27, 2009
Brian Orelli |
A Capitalist Pig's View of Swine Flu So you want to make money from the swine flu? Here's how to do so. |
Pharmaceutical Executive
April 1, 2006
Patrick Clinton |
Deal Making: Who's Coming to the Table Noteworthy license deals and alliances in the pharmaceutical industry. |
Smithsonian
January 2006
Michael Rosenwald |
The Flu Hunter For years, virologist Robert Webster has been warning of a global influenza outbreak. Now governments worldwide are finally listening to him. |
The Motley Fool
February 28, 2011
Brian D. Pacampara |
Next-Generation Drug Technologies Battle It Out Alnylam and Sangamo BioSciences have different ways to manipulate proteins to fight disease. |
InternetNews
March 24, 2008 |
STMicro Launches Microchip to Detect Bird Flu STMicroelectronics, said it has developed a portable chip to detect influenza viruses, including bird flu in humans. |
The Motley Fool
March 30, 2006
David Compton |
Glaxo's New Flu-Fighting Ammo The FDA certifies the drugmaker's Relenza for defense as well as offense. For investors seeking to give their portfolios a shot in the arm, now might be the time to take a closer look at Glaxo. |
Scientific American
November 2005 |
Preparing for the Worst Flu season comes every year as reliably as hurricane season. If America shores up our defenses against both, we will be in a much stronger position when the "big ones" hit. |
BusinessWeek
October 24, 2005
John Carey |
New Vaccines For A Pandemic Using DNA, vast amounts of flu vaccine could be made quickly. But will the drugs work? |
Chemistry World
July 24, 2009
Matt Wilkinson |
Pharma's shot in the arm? As swine flu cases continue to erupt around the globe, the latest financial results from pharmaceutical companies Roche and GlaxoSmithKline reveal that sales of their antiviral drugs have soared. |
Pharmaceutical Executive
December 1, 2005
Anthony Tao |
The Avian Few: Is it Too Late for Pharma to Re-enter the Vaccine Fray? Small profit margins and high litigation risks drove most companies out of the vaccine business decades ago. As a possible pandemic looms, pharma re-enters the fray. Is it too late? |
American Family Physician
January 15, 2004 |
Influenza Vaccine What is influenza?... Who is at higher risk?... What is the flu vaccine?... Is the vaccine safe?... etc. |
BusinessWeek
January 9, 2006
Carol Matlack |
Preventing The Pandemic France's Sanofi Pasteur is already signing contracts for an avian flu vaccine. |
Bio-IT World
December 15, 2004
David A. Bumcrot |
Identifying RNAi Drug Candidates Breakthroughs in understanding RNA's extensive role in essential cellular processes have opened up the potential for a whole new class of drugs based on RNAi. |
American Family Physician
October 1, 2004 |
Flu Vaccinations A general overview on what flu vaccines are and how they can help. |
Bio-IT World
November 2005
Nancy Weil |
Dharmacon, Institutes Form siRNA Global Initiative The company has formed a global alliance with leading biomedical research centers aimed at speeding scientific and medical discoveries now that the first complete siRNA (small interfering RNA) library is available for targeting genes in the human genome. |
The Motley Fool
October 17, 2005
Brian Gorman |
Chasing Down Bird Flu Sanofi and GlaxoSmithKline are emerging as the likely winners in the race to produce a bird flu vaccine. |
The Motley Fool
February 9, 2006
Jason Mac Gurn |
RNA: Rule Breaker Nucleic Acid Investors, new RNA-based technologies may be the next revolution in biopharmaceuticals. ISIS Pharmaceuticals... Sirna Therapeutics... Alnylam Pharmaceuticals... |
BusinessWeek
January 12, 2004
Gene G. Marcial |
Quidel: Flu Test Fever With influenza on a rampage, shares of Quidel are grabbing the Street's attention. |
Chemistry World
February 2006 |
Editorial: Fighting Avian Flu Participants at a world avian flu conference in Beijing committed to increasing cooperation on global vaccine and anti-viral research and development. |
Bio-IT World
December 15, 2004
Zachary Zimmerman |
Silence Is Golden Life Science Insights believes that RNAi therapeutics will dramatically affect the pharmaceutical and healthcare industries, becoming the next major class of therapeutics, joining small molecules, proteins, and monoclonal antibodies. |
The Motley Fool
November 30, 2010
Brian Orelli |
RNAi Is On Sale The novel technology looks more promising at these prices. |
The Motley Fool
June 12, 2009
Brian Orelli |
Be Careful What You Wish For Do you have the stomach to profit from swine flu? |
BusinessWeek
September 19, 2005
Catherine Arnst |
A Hot Zone In The Heartland Little could be done to contain a deadly avian flu outbreak. Right now, the U.S. has no national pandemic preparedness plan, either for treating large numbers of patients or for dealing with the resulting economic and social disruptions. |
Popular Mechanics
July 31, 2007
John Galvin |
Spanish Flu Pandemic: 1918 The influenza pandemic of 1918 killed an estimated 50 million people around the world -- 34 million more than died from the First World War in progress alongside it. |
The Motley Fool
July 11, 2007
Brian Orelli |
Everybody Loves RNAi Roche is the latest firm to (over)pay for the hottest new drug technology. Alnylam announced that it licensed some of its intellectual property to Roche for $331 million. Investors, take note. |
The Motley Fool
September 24, 2010
Brian Orelli |
So Long and Thanks for All the Drug Candidates Alnylam and Novartis end their five-year partnership. |
Chemistry World
May 29, 2013
Hayley Birch |
Fast flu mapping without the sequencing Australian researchers showed that using data from flu virus proteins produced similar trees to those generated by genetic sequencing, suggesting a rapid-fire solution for identifying viruses during outbreaks. |
Bio-IT World
July 15, 2003
Malorye Branca |
Silence Is Golden RNA interference's scientific, therapeutic, and economic potential is unquestionable, but some sticky questions still remain. |
Managed Care
February 2005
Jack McCain |
Managed Care (and Everyone Else) Unprepared for the Next Killer Flu Could avian flu give rise to a pandemic that might rival the fearsome Spanish flu? Is the nation ready? Health plans may be called upon to administer vaccinations and identify high-risk patients, but what about he millions of Americans who lack health insurance? |
The Motley Fool
October 28, 2005
Rich Duprey |
Chiron's Bird Flu Contract As Asian bird flu becomes the crisis du jour, this flu vaccine biotech is awarded a hefty contract. |
Pharmaceutical Executive
September 1, 2005
Patrick Clinton |
From the Editor: It Never Changes (Until It Does) Change is bubbling around through the industry, its customers, and its regulators. Should pharmaceutical companies be doing the equivalent of taking two aspirin and calling in the morning or building an ark? |
American Family Physician
January 15, 2006
Liz Smith |
Newsletter New Grants Support Exchange of Local and State Health Information... Research Training Grants Awarded to Help Fight AIDS and Tuberculosis... FDA Warns Companies Marketing Fraudulent Therapies for Avian Flu... etc. |
Health
June 19, 2009
Ginny Graves |
How to Combat the Latest Supergerms While some germs may be outpacing our ability to kill them, we're not completely defenseless. In fact, there are plenty of things we can do to slow their spread. |
Popular Mechanics
March 2006
Jeff Wise |
Fighting Fire With Fire By recreating an extinct virus that killed as many as 50 million people, scientists race to defeat avian flu before it evolves into a deadlier form. |
The Motley Fool
August 1, 2007
Brian Orelli |
RNAi Gets Pumped Up Is a collaboration between RNAi expert Alnylam Pharmaceuticals and medical-device maker Medtronic something investors can endorse? |
